MedTech Europe’s Bisazza: How Expert Panel Delays Have Caused Uncertainty For Companies
Executive Summary
Medtech manufacturers are substantially ready to demonstrate compliance with the EU MDR for new high-risk devices, but the system for checking notified body reviews of their clinical work is causing hold-ups for some highly innovative products, MedTech Europe’s Oliver Bisazza told Medtech Insight in a recent interview.